WeGene
PrivateLast Round
Series C
Jan 26, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
WeGene is a biotechnology company that provides personal genetic testing, genomic data analysis, and personalized healthcare services with a focus on East Asian populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WeGene Comparables
Compare WeGene with similar companies based on industry and business-model similarity.
WeGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 26, 2022 | ||||
| Strategic | Jul 5, 2018 | ||||
| Series B | Jan 29, 2018 | ||||
| Series A | Sep 1, 2015 | ||||
| Angel | Aug 17, 2015 |
WeGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ameba Capital | Series B |
| 险峰K2VC | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 78% MoM, reaching 57K.
- Jan 5, 2026
Monthly visitors increased 35% MoM.
WeGene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WeGene's valuation, stock price, and market status.
Is WeGene a public or private company?
WeGene is a private company.
What is the current stock price of WeGene?
WeGene is a private company with no public stock price. No recent secondary market data is available.
How much is WeGene worth (valuation)?
Valuation information for WeGene is not publicly available.
Can I buy WeGene stock?
WeGene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WeGene's last funding round?
Funding round information for WeGene is not publicly available.
Who are the main investors in WeGene?
Investor information for WeGene is not publicly disclosed.
Will WeGene IPO soon?
No public IPO plans have been announced for WeGene.
How can I track WeGene secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WeGene's secondary market activity and sign up for updates.